Study met primary endpoint of ≥15-letter (≥3-line) gain in mesopic low contrast distance visual acuity in comparison to placebo Phase 3 study showed patient-reported functional benefit in treating ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Multifocal and single vision lenses performed similarly ...

VIENNA, Austria — Compared with subcutaneous interferon β-1a (IFNB-1a; Rebif/EMD Serono/Pfizer), treatment with alemtuzumab (Lemtrada, Genzyme/Sanofi) improved visual outcomes in treatment-naive ...

"You're not ugly, you're just not doing your makeup based on your contrast level," the most recent viral sound on TikTok tells me as soon as I open the app – bleary-eyed and half asleep at 1am. The ...